Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema
试验速览
- 阶段
- 1 期
- 试验地点
- 1
研究概览
简要总结
Diffuse Macular Edema is the main cause of visual disorders in diabetic patients.
Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.
详细描述
Diffuse Macular Edema is the main cause of visual disorders in diabetic patients.
Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.
研究设计
- 研究类型
- Interventional
- 干预模型
- Parallel
- 主要目的
- Treatment
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients with clinically significant macular edema and diffuse macular edema
排除标准
- •any history of focal photocoagulation
- •any prior intra ocular injection
- •history of glaucoma with high pressure
- •history of ophthalmic surgery
- •high rish PDR
- •active PDR
研究组 & 干预措施
Avastin
干预措施: Bevacizumab (Drug)
Diclofenac
干预措施: Diclofenac (Drug)